drugset / Trial / NCT00441246
Phase 4 Study - Mucinex D as Adjunct Therapy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Timeline
- Start
- 2007-02
- Primary completion
- 2007-05
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guaifenesin | Small molecule | 600 mg | — |
| Subject | Pseudoephedrine | Small molecule | 60 mg | — |